Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,449 | 82,673 | 62,936 | 39,661 | 77,123 |
| Marketable Securities | 335,907 | 396,717 | 415,667 | 445,820 | 387,174 |
| TOTAL | $430,031 | $494,377 | $495,981 | $499,533 | $480,836 |
| Non-Current Assets | |||||
| PPE Net | 46,732 | 47,481 | 47,195 | 36,955 | 25,162 |
| Investments And Advances | 39,886 | 23,534 | 55,832 | 97,554 | 147,881 |
| Other Non-Current Assets | 36,582 | 37,586 | 38,596 | 42,554 | 8,105 |
| TOTAL | $123,200 | $108,601 | $141,623 | $177,063 | $181,148 |
| Total Assets | $553,231 | $602,978 | $637,604 | $676,596 | $661,984 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,590 | 2,022 | 3,931 | 3,662 | 1,891 |
| Accrued Expenses | N/A | 15,467 | 13,793 | 12,114 | N/A |
| Other current liabilities | 42,754 | 29,196 | 28,825 | 27,468 | 30,895 |
| TOTAL | $45,344 | $46,685 | $46,549 | $43,244 | $32,786 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 112,997 | 118,096 | 115,882 | 116,704 | 82,353 |
| TOTAL | $112,997 | $118,096 | $115,882 | $116,704 | $82,353 |
| Total Liabilities | $158,341 | $164,781 | $162,431 | $159,948 | $115,139 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,423 | 96,031 | 95,842 | 95,478 | 95,289 |
| Common Shares | 1,288 | 1,286 | 1,283 | 1,279 | 1,273 |
| Retained earnings | -425,551 | -371,526 | -325,266 | -266,929 | -227,937 |
| Other shareholders' equity | 350 | 562 | 879 | 332 | -649 |
| TOTAL | $394,890 | $438,197 | $475,173 | $516,648 | $546,845 |
| Total Liabilities And Equity | $553,231 | $602,978 | $637,604 | $676,596 | $661,984 |